BioCentury
ARTICLE | Financial News

Illumina beats the Street on strong NovaSeq sales

August 2, 2017 8:56 PM UTC

Illumina Inc. (NASDAQ:ILMN) jumped $25.55 (15%) to $197.85 Wednesday after reporting earnings late Tuesday that were ahead of the Street's expectations. The move corresponded to a $3.7 billion bump in market cap.

Illumina reported 2Q17 EPS of $0.82 on revenues of $662 million; analysts were expecting $0.69 and $642.4 million, respectively. The microarray company also guided to the high end of its prior 2017 revenue guidance and now expects revenue to grow 12% versus 2016. In April, the company said it expected 10-12% growth. 2016 revenues were $2.4 billion...

BCIQ Company Profiles

Illumina Inc.